Companies VALUES CREATE +++ NEWS +++ Change in management with effect from March 1, 2021 Continue reading " COMPANIES PRODUCTS INVESTOR RELATIONS CAREER NEWS DE ENG IMPRINT DATA PROTECTION CONDITIONS CONTACT This site uses website tracking technologies from third parties in order to offer its services, to continuously improve them and to display advertisements in line with the interests of the users. I agree and can revoke or change my consent at any time with effect for the future. REFUSE ACCEPT MORE Powered by

COMPANIES PRODUCTS INVESTOR RELATIONS CAREER NEWS DE ENG IR contact Contact form. Salutation * - Mrs Mr Diverse Name * First name * Company * function phone Email * I am * - TLB investor HYB investor Both Interested in becoming an investor Interested in anything else comment Consent to data protection * I have read the data protection declaration. I agree that my details and data will be electronically collected and stored to answer my request. Note: You can revoke your consent at any time for the future by sending an email to datenschutz (at) cheplapharm.com . Verification* SEND Headquarter / Office CHEPLAPHARM Arzneimittel GmbH Ziegelhof 24 17489 Greifswald investor-relations (at) cheplapharm.com Investor Relations IR News Financing strategy Ratings Financial reports ESG information Investors Domain IR contact IR newsletter IMPRINT DATA PROTECTION CONDITIONS CONTACT This site uses website tracking technologies from third parties in order to offer its services, to continuously improve them and to display advertisements in line with the interests of the users. I agree and can revoke or change my consent at any time with effect for the future. REFUSE ACCEPT MORE Powered by